On April 17, the opening ceremony of the 24th Harvard China Forum and the 12th China-US Business Leaders Roundtable Conference were held in Beijing.
The conference invited more than 20 entrepreneurs and scholars from China and the United States through a combination of online and offline methods to discuss how to "rebuild mutual trust and meet changes together.
In the roundtable dialogue on "Development and Challenges of the Big Health Industry in the Post-epidemic Era", Chen Dongsheng, Founder, Chairman and CEO of Taikang Insurance Group Co.
, Chairman of Yabuli Forum, Founder of Yuanming Capital, Chairman of Maisheng Medical Group , Tian Yuan, Founder and Chairman of Yabuli Forum, Zhang Ligang, Founder, Chairman and CEO of Akcome Group, President of JuneYao Group, Chairman of JuneYao Health, Wang Junhao, Director of Yabuli Forum, and Liu Guoen, Dean of Peking University Global Health Development Institute, in-depth discussion In view of the development trend and policy development of the big health industry, Zhu Dan, a researcher at the National Institute of Development and Strategy, Renmin University of China, presided over this dialogue.
The following is the content of the conversation:
Zhu Dan: After experiencing the baptism of the COVID-19 pandemic in 2020, "life is first, health first" has become the consensus of the world, and the big health industry has ushered in an unprecedented window of development.
First of all, please have a chat: What are the trends in the big health industry in the post-epidemic era?
Chen Dongsheng: Last year I mentioned that human beings are entering the era of longevity, which means that a hundred-year-old life is coming, and at the same time, everyone will live for a long time with illness.
The age of longevity must be the age of health, wealth, and even the age of longevity economy.
If the industrial era solves the problems of "clothing, food, housing, and transportation", then the post-industrial era solves the problems of "entertainment, education, medical care, and support", and health has become the focus of attention.
Especially after the new crown epidemic, the entire country and society have paid more attention to health.
This trend is affirmative.
Liu Guoen: I understand the development opportunities of the big health industry in the post-epidemic era.
Although this epidemic has not been seen in a century, it is just a small wave from the perspective of the general development trend of the health industry.
Why do you say that? At the beginning of the new century, Robert Fogel, a Nobel Prize economist at the University of Chicago, based on the analysis of long-term historical data, pointed out that as income levels continue to increase, people will continue to increase R&D and production investment for health promotion and life extension.
Medical and health care is destined to become a sunrise industry that will dominate the economies of all countries in the new century.
Recent forecasting studies indicate that by 2050, China's medical and health service economy will likely reach 20% of GDP, surpassing the current US level of 18%.
Therefore, future research should pay more attention to the issue of efficiency, that is, how can up to 20% of the resources of the macro economy be invested in the health industry, how can the efficiency of resource allocation be improved as much as possible? If the efficiency is high, it is not a problem if China's medical and health services reach 20% or more of GDP.
On the contrary, if there is a huge inefficiency or waste, it is a big problem.
Tian Yuan: Dean Liu used statistical data to speculate that in the next 20 or 30 years, the health industry spending will reach a very large proportion of China's GDP, but he is more concerned about the efficiency of input and output, and I will respond.
If the medicines and equipment of the big health industry are imported from abroad, the efficiency will be relatively low.
In the past, many of the medicines and medical equipment used by the Chinese were imported.
If China’s medical and health expenditures are all imported, there will definitely be inefficiencies.
Fortunately, there has been great development in the past five years.
China has moved from the third echelon of global new drug research and development to the second echelon.
PE/VC investment has risen from more than 10 billion to more than 170 billion.
Biopharmaceutical companies are emerging in endlessly, and there are many more.
Innovative drugs are constantly being developed in the United States and Hong Kong for listing.
The same is true for medical equipment.
For example, CT and nuclear magnetic equipment in major hospitals in China are mostly foreign brands, and no Chinese company has entered the world's top 30 in this industry.
However, great changes have also taken place over the years, and a number of local medical equipment companies are emerging.
More policy support will improve efficiency and make big health investments produce greater social effects.
Zhang Ligang: The development of general health care must be inseparable from top-level medical care.
Organizations that provide medical services often advocate providing top-level medical services to customers and patients.
However, the scarcity of medical resources is an objective fact.
If a company depends on scarce resources for development, it is impossible to successfully build a large-scale medical service system.
The new crown epidemic has forced changes in medical service models around the world, catalyzing the development of the Internet, artificial intelligence, and medical big data in the healthcare industry.
Judging from the current increase in health investment in the whole society, the importance of my country's medical and health expenditure in the national economy has gradually increased, but there is still room for growth compared with developed countries.
How much of this is spent on prevention and how much is spent on treatment determines the quality of life of the Chinese population.
There are many methods of preventive medicine, the two most important of which are vaccination and physical examination.
Compared with traditional physical examinations, genetic testing and AI technology can help us better predict disease risks.
Especially through this epidemic, the big health industry has entered an era of strong public demand.
The Internet, medical big data, and artificial intelligence will accelerate the development of the industry and accelerate investors’ investment in this field.
The big health industry will usher in new opportunities.
Period and more "blue ocean".
Wang Junhao: The country's "Healthy China" strategy is very forward-looking.
As a food and beverage company, how to connect with the field of "Kang" is one of my thoughts.
We originally made lactic acid bacteria beverages and milk.
When JuneYao Dairy was preparing to go on the market a few years ago, we changed its name to JuneYao Health and switched to a new track such as probiotics.
People often say "prevent disease".
In the future, food is very important to people's health.
Everyone should think about how to industrialize the food industry.
The development in the post-epidemic era is also the development of "health + technology".
I have also been thinking about how entrepreneurs can transform scientific and technological achievements and how to integrate production, education and research.
These are important things we all want to do.
After the epidemic, consumers' perceptions and eating habits have been constantly changing and improving.
Therefore, China's big health industry will explode in the future.
I also hope that when our food is exported, the country will give more support.
Zhu Dan: Great health is a human-centered subject, involving at least four dimensions: the first is people and society, such as social mutual assistance and protection through systems; the second is people and nature, and only people can be under a good natural environment.
The third is people and themselves, everyone must have a healthy life>What Mr.
Wang just said was to analyze industry trends from the perspective of "people and oneself".
Next, let’s talk about policies.
What do you think of the policies related to health in the 14th Five-Year Plan? Will there be better policies in the future?
Chen Dongsheng: Taikang used to be a life insurance company.
It started to enter the pension field 14 years ago.
Our strategy is very clear, which is to do a good job in insurance and provide physical services for medical and pension services at the same time.
In the process of innovation, we have received policy support from the China Banking and Insurance Regulatory Commission, the National Development and Reform Commission and other departments.
National policies encourage life insurance companies to invest in and enter the medical and pension fields.
Taikang has also explored a new business model that combines virtual insurance, finance with physical medical care and services, extending the industry value chain, focusing on customers’ full life cycle health and longevity services, and allowing the insurance industry to truly serve people.
The health and elderly care needs of China have also established their own advantages in the industry.
China's success today is that it has given full play to the advantages of late-developing countries and has always encouraged innovation and technological development in various fields.
Taikang has just taken the path of innovation, so it made today's new business model.
In the field of general health, I proposed the "Taikang Plan for Longevity Era".
The age of longevity must be the age of health, but also the age of investment and wealth.
Longevity, health, and wealth, the three of them have built the longevity economy of the future.
Every year a person’s life span is extended, major health expenditures will increase.
Today, there are 250 million people over the age of 60 in China.
Can society as a whole accept such a severe challenge? How does social policy need to intervene? I believe that the challenges of the longevity era are more important than the challenges of blockchain and 5G.
Liu Guoen: In the "Outline of the "Healthy China 2030 Plan"" issued in 2016, the policy statement is actually very comprehensive.
This year's "Two Sessions", the government work report once again emphasized that it requires better implementation of relevant measures for a healthy China.
How to understand the key to the goal of promoting a healthy China, the following three aspects are very important.
The first is the involvement of the whole industry.
To effectively improve the health of the whole people, all departments and industries that affect the health risks of residents must be coordinated and involved, and the treatment actions of the medical and health teams cannot be relied on alone.
The second is full life cycle management.
To achieve a "healthy China", one cannot only look at the current health problems of the body.
Many problems may be buried in the early stages of life.
Therefore, if the whole life cycle is managed well, the later medical interventions can be more effective.
The third is universal participation.
In addition to government and social measures, if residents can actively participate in the promotion of healthy behaviors, the overall effect will naturally be higher.
We still have many measures and great potential to better achieve the grand goal of a healthy China, especially the continued reform and opening up and institutional innovation, to further liberate personal productivity, and allow 1.
4 billion people’s brains to better play the role of generating new ideas and sharing new ideas.
, Forming a huge source of innovation in China.
Finally, in the era of information civilization, data is the most important productivity.
In addition to the theoretical innovation and method technology that promote the information revolution, it is also important to how to make the massive amount of data generated by the whole society every day to enable research institutions to obtain the most effective systematic acquisition and application analysis, so that it can be truly transformed into a key force in the promotion of China's information civilization.
At the same time, big data involves many complex issues such as national security and personal privacy, but the pace of the information revolution does not wait for others.
Therefore, it is particularly necessary for everyone to work together to introduce relevant policies, regulations and technical means as soon as possible, so that big data can ensure security and privacy.
Under the premise, it can be used legally and effectively in accordance with regulations and truly play its role as an important productive force in the information age.
Zhu Dan: Thank you, Dean Liu.
The big health industry has become one of the largest industries in the world, and my country's big health industry is also developing rapidly.
There are still many opportunities in this field, such as the sinking of medical services, how to revitalize the grassroots medical system, and so on.
The dividends of population growth have disappeared, but there is still a lot of room for structural dividends.
Unbalanced regional development and unbalanced urban-rural development are still service directions and market opportunities that the big health industry should pay attention to.